YARTEMLEASSURE PATIENT SUPPORT PROGRAM
DEAD

Serial Number

90739907

Owner

Omeros Corporation

Attorney

Anne H. Peck

Filing Date

May 27, 2021

Add to watchlist:

No watchlists yet
View on USPTO

YARTEMLEASSURE PATIENT SUPPORT PROGRAM Trademark

Serial Number: 90739907

YARTEMLEASSURE PATIENT SUPPORT PROGRAM is a trademark filed by Omeros Corporation on May 27, 2021. The trademark is classified under Class 36 (Insurance & Financial), Class 41 (Education & Entertainment), Class 16 (Paper Goods), Class 35 (Advertising & Business). The application is currently no longer active.

Owner Contact Info

Omeros Corporation (107 trademarks)

Attn: Marcia S. Kelbon
Seattle, WA 98101

Entity Type: 03

Trademark Details

Filing Date

May 27, 2021

Registration Date

Not Registered

Published for Opposition

March 15, 2022

Goods & Services

Educational services, namely, conducting educational programs in the fields of endothelial diseases and disorders, renal diseases, transplant complications, ischemia-reperfusion injury and hematological, autoimmune, neurological, immunological and inflammation-related disease and disorders and treatment and patient support options for these conditions

Printed publications in the nature of brochures, pamphlets, newsletters, written articles and guidebooks in the field of medical information and patient support

Providing a website featuring financial information regarding medical benefits and reimbursements available for medical expenses related thereto; and insurance services, namely, benefits verification in the nature of insurance claims administration; providing online information and financial assistance with insurance benefits and coverage for health care providers and patients in the field of endothelial diseases and disorders, renal diseases, transplant complications, ischemia-reperfusion injury and hematological, autoimmune, neurological, immunological and inflammation-related disease and disorders

Promoting awareness of patient support offerings for endothelial diseases and disorders, renal diseases, transplant complications, ischemia-reperfusion injury and hematological, autoimmune, neurological, immunological and inflammation-related disease and disorders; business administration of reimbursement and medical benefit information for endothelial diseases and disorders, renal diseases, transplant complications, ischemia-reperfusion injury and hematological, autoimmune, neurological, immunological and inflammation-related disease and disorders and their treatment; and business administrative services for medical referrals

Filing History

ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Dec 18, 2023 MAB6
ABANDONMENT - NO USE STATEMENT FILED
Dec 18, 2023 ABN6
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Mar 28, 2023 EXRA
SOU EXTENSION 2 GRANTED
Mar 24, 2023 EX2G
SOU EXTENSION 2 FILED
Mar 24, 2023 EXT2
SOU TEAS EXTENSION RECEIVED
Mar 24, 2023 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Oct 21, 2022 EXRA
SOU EXTENSION 1 GRANTED
Oct 19, 2022 EX1G
SOU EXTENSION 1 FILED
Oct 19, 2022 EXT1
SOU TEAS EXTENSION RECEIVED
Oct 19, 2022 EEXT
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
May 10, 2022 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Mar 15, 2022 NPUB
PUBLISHED FOR OPPOSITION
Mar 15, 2022 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Feb 23, 2022 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Feb 9, 2022 CNSA
EXAMINER'S AMENDMENT ENTERED
Feb 9, 2022 XAEC
ASSIGNED TO LIE
Feb 9, 2022 ALIE
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Feb 9, 2022 GNEN
EXAMINERS AMENDMENT E-MAILED
Feb 9, 2022 GNEA
EXAMINERS AMENDMENT -WRITTEN
Feb 9, 2022 CNEA
ASSIGNED TO EXAMINER
Feb 9, 2022 DOCK
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Nov 24, 2021 CHAN
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Nov 24, 2021 TCCA
TEAS CHANGE OF OWNER ADDRESS RECEIVED
Nov 24, 2021 COAR
NOTICE OF DESIGN SEARCH CODE E-MAILED
Aug 24, 2021 MDSM
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Aug 23, 2021 NWOS
NEW APPLICATION ENTERED
May 31, 2021 NWAP